mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.4 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |